Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kim, Changyoun ^a,b   Lv, Guohua ^c   Lee, Jun Sung ^a   Jung, Byung Chul ^a,d   Masuda Suzukake, Masami ^e   Hong, Chul Suk ^a   Valera, Elvira ^b   Lee, He Jin ^f   Paik, Seung R ^a   Hasegawa, Masato ^e   Masliah, Eliezer ^b   Eliezer, David ^c   Lee, Seung Jae ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Yonsei University Wonju   (South Korea)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; LIPOPOLYSACCHARIDE; PROTEIN AGGREGATE;

ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; METABOLISM; MICROGLIA; MOUSE; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SHY DRAGER SYNDROME;

ALPHA-SYNUCLEIN; AMYLOID; ANIMALS; CELLS, CULTURED; FEMALE; HUMANS; LEWY BODY DISEASE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; MULTIPLE SYSTEM ATROPHY; NEURONS; PARKINSON DISEASE; PROTEIN AGGREGATES; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT;

EID: 84982797304     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30891     Document Type: Article

References (44)

1. Peggion, C., Sorgato, M. C., Bertoli, A. Prions and prion-like pathogens in neurodegenerative disorders. Pathogens 3, 149-163, doi: 10.3390/pathogens3010149 (2014).
2. Collinge, J., Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930-936, doi: 10.1126/science.1138718 (2007).
3. Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M., Weissmann, C. Darwinian evolution of prions in cell culture. Science 327, 869-872, doi: 10.1126/science.1183218 (2010).
4. Brundin, P., Melki, R., Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature reviews. Molecular cell biology 11, 301-307, doi: 10.1038/nrm2873 (2010).
5. Brettschneider, J., Del Tredici, K., Lee, V. M., Trojanowski, J. Q. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16, 109-120, doi: 10.1038/nrn3887 (2015).
6. McCann, H., Stevens, C. H., Cartwright, H., Halliday, G. M. alpha-Synucleinopathy phenotypes. Parkinsonism & related disorders 20 Suppl 1, S62-67, doi: 10.1016/S1353-8020(13)70017-8 (2014).
7. Bousset, L. et al. Structural and functional characterization of two alpha-synuclein strains. Nature communications 4, 2575, doi: 10.1038/ncomms3575 (2013).
8. Tycko, R. Amyloid Polymorphism: Structural Basis and Neurobiological Relevance. Neuron 86, 632-645, doi: 10.1016/j. neuron.2015.03.017 (2015).
9. Peelaerts, W. et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340-344, doi: 10.1038/nature14547 (2015).
10. Abdulwahid Arif, I., Ahmad Khan, H. Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress. Toxicol Ind Health 26, 121-128, doi: 10.1177/0748233710362382 (2010).
11. Bu, X. L. et al. The association between infectious burden and Parkinson's disease: A case-control study. Parkinsonism Relat Disord 21, 877-881, doi: 10.1016/j.parkreldis.2015.05.015 (2015).
12. De Chiara, G. et al. Infectious agents and neurodegeneration. Mol Neurobiol 46, 614-638, doi: 10.1007/s12035-012-8320-7 (2012).
13. Harris, M. A., Tsui, J. K., Marion, S. A., Shen, H., Teschke, K. Association of Parkinson's disease with infections and occupational exposure to possible vectors. Mov Disord 27, 1111-1117, doi: 10.1002/mds.25077 (2012).
14. He, Q. et al. Intranasal LPS-mediated Parkinson's model challenges the pathogenesis of nasal cavity and environmental toxins. PLos One 8, e78418, doi: 10.1371/journal.pone.0078418 (2013).
15. Kelly, L. P. et al. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord 29, 999-1009, doi: 10.1002/mds.25736 (2014).
16. Kim, C. et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4, 1562, doi: 10.1038/ncomms2534 (2013).
17. Lee, J. H. et al. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1. The Biochemical journal 418, 311-323, doi: 10.1042/BJ20081572 (2009).
18. Gath, J. et al. Solid-state NMR sequential assignments of alpha-synuclein. Biomolecular NMR assignments 6, 51-55, doi: 10.1007/s12104-011-9324-3 (2012).
19. Comellas, G. et al. Structured regions of alpha-synuclein fibrils include the early-onset Parkinson's disease mutation sites. Journal of molecular biology 411, 881-895, doi: 10.1016/j.jmb.2011.06.026 (2011).
20. Sacino, A. N. et al. Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta neuropathologica 127, 645-665, doi: 10.1007/s00401-014-1268-0 (2014).
21. Masuda-Suzukake, M. et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain: a journal of neurology 136, 1128-1138, doi: 10.1093/brain/awt037 (2013).
22. Yonetani, M. et al. Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant. The Journal of biological chemistry 284, 7940-7950, doi: 10.1074/jbc.M807482200 (2009).
23. Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953, doi: 10.1126/science.1227157 (2012).
24. Guo, J. L. et al. Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103-117, doi: 10.1016/j. cell.2013.05.057 (2013).
25. Jucker, M., Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45-51, doi: 10.1038/nature12481 (2013).
26. Bussell, R. Jr., Eliezer, D. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J Mol Biol 329, 763-778 (2003).
27. Santos, N. C., Silva, A. C., Castanho, M. A., Martins-Silva, J., Saldanha, C. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem 4, 96-100, doi: 10.1002/cbic.200390020 (2003).
28. Lee, H. J., Choi, C., Lee, S. J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277, 671-678, doi: 10.1074/jbc.M107045200 (2002).
29. Necula, M., Chirita, C. N., Kuret, J. Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro. J Biol Chem 278, 46674-46680, doi: 10.1074/jbc.M308231200 (2003).
30. Anderson, V. L., Ramlall, T. F., Rospigliosi, C. C., Webb, W. W., Eliezer, D. Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation. Proc Natl Acad Sci USA 107, 18850-18855, doi: 10.1073/pnas.1012336107 (2010).
31. Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during alpha-synuclein fibril formation. Proc Natl Acad Sci USA 112, E1994-2003, doi: 10.1073/pnas.1421204112 (2015).
32. Kubota, T. et al. Direct evidence of generation and accumulation of beta-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for beta-form prion protein. J Biol Chem 287, 14023-14039, doi: 10.1074/jbc.M111.318352 (2012).
33. Braak, H., Del Tredici, K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70, 1916-1925, doi: 10.1212/01.wnl.0000312279.49272.9f (2008).
34. Lee, H. J. et al. Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers. Experimental & molecular medicine 43, 216-222, doi: 10.3858/emm.2011.43.4.026 (2011).
35. Eliezer, D., Kutluay, E., Bussell, R. Jr., Browne, G. Conformational properties of alpha-synuclein in its free and lipid-associated states. Journal of molecular biology 307, 1061-1073, doi: 10.1006/jmbi.2001.4538 (2001).
36. Dikiy, I., Eliezer, D. N-terminal acetylation stabilizes N-terminal helicity in lipid-and micelle-bound alpha-synuclein and increases its affinity for physiological membranes. The Journal of biological chemistry 289, 3652-3665, doi: 10.1074/jbc.M113.512459 (2014).
37. Morcombe, C. R., Zilm, K. W. Chemical shift referencing in MAS solid state NMR. J Magn Reson 162, 479-486 (2003).
38. Metz, G., Wu, X. L., Smith, S. O. Ramped-Amplitude Cross-Polarization in Magic-Angle-Spinning Nmr. J Magn Reson Ser A 110, 219-227, doi: 10.1006/jmra.1994.1208 (1994).
39. Hediger, S., Meier, B. H., Ernst, R. R. Adiabatic Passage Hartmann-Hahn Cross-Polarization in Nmr under Magic-Angle Sample-Spinning. Chem Phys Lett 240, 449-456, doi: 10.1016/0009-2614(95)00505-X (1995).
40. Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V., Griffin, R. G. Heteronuclear Decoupling in Rotating Solids. J Chem Phys 103, 6951-6958, doi: 10.1063/1.470372 (1995).
41. Takegoshi, K., Nakamura, S., Terao, T. C-13-H-1 dipolar-assisted rotational resonance in magic-angle spinning NMR. Chem Phys Lett 344, 631-637, doi: 10.1016/S0009-2614(01)00791-6 (2001).
42. Masuda-Suzukake, M. et al. Pathological alpha-synuclein propagates through neural networks. Acta neuropathologica communications 2, 88, doi: 10.1186/s40478-014-0088-8 (2014).
43. Kim, C. et al. Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy. Cell reports 13, 771-782, doi: 10.1016/j.celrep.2015.09.044 (2015).
44. Kim, C. et al. Hypoestoxide reduces neuroinflammation and alpha-synuclein accumulation in a mouse model of Parkinson's disease. J Neuroinflammation 12, 236, doi: 10.1186/s12974-015-0455-9 (2015).